Evidence map›Paper›PMID 34112807›Full record

ArticleNPJ Parkinson's disease2021

A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson's disease.

Agnes Langer, Sebastian Hasenauer, Anna Flotz, Lucia Gassner, Rochus Pokan, Peter Dabnichki, Laurenz Wizany, Jakob Gruber, Dominik Roth, Sarah Zimmel and 5 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. The Origin, Application and Mechanism of Therapeutic Climbing: A Narrative Review.International journal of environmental research and public health · 2022
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Agnes LangerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-9932-0474
Sebastian HasenauerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Anna FlotzDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Lucia GassnerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Rochus PokanDepartment of Sport Physiology, Institute of Sports Sciences, University of Vienna, Vienna, Austria.
Peter DabnichkiSchool of Engineering, RMIT University, Melbourne, VIC, Australia.
Laurenz WizanyDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Jakob GruberDepartment of Neurology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-5915-618X
Dominik RothDepartment of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Sarah ZimmelDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Marco TrevenDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Michaela SchmoegerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Ulrike WillingerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Walter MaetzlerDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.ORCID http://orcid.org/0000-0002-5945-4694
Heidemarie ZachDepartment of Neurology, Medical University of Vienna, Vienna, Austria. heidemarie.zach@meduniwien.ac.at.ORCID http://orcid.org/0000-0003-3622-3831
Medical University of Vienna · ATUniversity of Vienna · ATChristian-Albrechts-Universität zu Kiel · DERMIT University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physical activity is of prime importance in non-pharmacological Parkinson's disease (PD) treatment. The current study examines the effectiveness and feasibility of sport climbing in PD patients in a single-centre, randomised controlled, semi-blind trial. A total of 48 PD patients without experience in climbing (average age 64 ± 8 years, Hoehn & Yahr stage 2-3) were assigned either to participate in a 12-week sport climbing course (SC) or to attend an unsupervised physical training group (UT). The primary outcome was the improvement of symptoms on the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS-III). Sport climbing was associated with a significant reduction of the MDS-UPDRS-III (-12.9 points; 95% CI -15.9 to -9.8), while no significant improvement was to be found in the UT (-3.0 points; 95% CI -6.0 to 0.1). Bradykinesia, rigidity and tremor subscales significantly improved in SC, but not in the unsupervised control group. In terms of feasibility, the study showed a 99% adherence of participants to climbing sessions and a drop-out rate of only 8%. No adverse events occurred. This trial provides class III evidence that sport climbing is highly effective and feasible in mildly to moderately affected PD patients.

Identifiers

PMID34112807
PMCPMC8192917
OpenAlexW3168177040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.